Measuring throat sensation with an endoscopic esthesiometer in people with obstructive sleep apnea
Official title: Accuracy of the Sensory Test Performed Using the Laryngopharyngeal Endoscopic Esthesiometer and Rangefinder in Patients With Suspected Obstructive Sleep Apnoea Hypopnea (OSA): a Prospective Double-blinded, Randomised, Pilot Study
Run by Fundación Neumologica Colombiana · NCT03109171 · Data updated 2026-11-12
This test tries to see if a new endoscopic device can reliably measure throat (laryngopharyngeal) sensation in adults referred for suspected obstructive sleep apnea.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 117 (estimated) |
| Sponsor | Fundación Neumologica Colombiana Academic / other |
| Drugs / interventions | prednisone |
| Locations | 2 sites (Bogotá, Bogota D.C. and 1 other locations) |
| Status | Recruiting |
| Started | January 1, 2018 |
| Main results expected | September 30, 2026 |
| Study ends | November 30, 2026 |
| Registry record updated | January 8, 2026 |
| Trial ID | NCT03109171 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (18+) referred to the participating tertiary sleep laboratories for a baseline polysomnography because OSA is suspected are eligible.
✕Probably not a fit
People on anticoagulation, with bleeding diathesis, resting oxygen saturation <88%, altered consciousness (GCS <15), or an invalid or outdated baseline polysomnogram are excluded and unlikely to benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a prospective, double-blinded, randomized crossover study using a laryngopharyngeal endoscopic esthesiometer and rangefinder (LPEER) that delivers calibrated air-pulses to measure sensory thresholds at the velopharynx, hypopharynx, and aryepiglottic folds. Adult patients referred for baseline polysomnography at two tertiary sleep centers will undergo LPEER testing, with raters crossed and blinded to randomize order. Reliability will be quantified with Bland-Altman plots, intraclass correlation coefficients, and correlation coefficients, while diagnostic accuracy will be analyzed by ROC curves using the baseline polysomnogram as the reference standard. Sensory thresholds will be compared across mild, moderate, and severe OSA groups using ANOVA or nonparametric equivalents depending on data distribution.
Why it matters
Potential benefit: If successful, this could provide a reliable bedside measure of laryngopharyngeal sensitivity that helps phenotype OSA and guide targeted management.
How similar studies have gone: Previous studies have suggested laryngopharyngeal hyposensitivity in OSA but used methods with weak reliability, so the LPEER approach is relatively novel and not yet widely validated.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients being 18 years old or more referred to the sleep laboratory of a tertiary care university hospital for a baseline polysomnography for suspected OSA. Exclusion Criteria: * Anticoagulation (though not a contraindication for the endoscopic laryngopharyngeal sensory test, anticoagulation is an exclusion criteria for this validation study in order to keep it a minimal-risk study). * Bleeding diathesis. * Basal awake oxygen saturation by pulse oximetry below 88%. * Not agree to participate in the study. * Glasgow coma scale below of 15 (to avoid confusion with involvement of laryngopharyngeal reflexes due to neurological disease accompanied by decreased level of consciousness). * Baseline polysomnography that does not meet validity criteria to be interpreted (according to the American Academy of Sleep Medicine). * Baseline polysomnography performed more than 15 days before the sensory testing. Ordinarily, the sensory testing will be performed the same day or the next day of baseline polysomnography. * More than 5% of total apnoea events being of central origin. * History of maxillofacial or pharyngeal surgery (to avoid confusion with involvement of laryngopharyngeal reflexes due to surgery in this region). * Laryngopharyngeal tract malignancies (to avoid confusion with involvement of laryngopharyngeal reflexes due to tumours). * Central Nervous System (CNS) surgery in the last three months or that has left neurological sequelae (to avoid confusion with involvement of laryngopharyngeal reflexes due to sequelae of CNS surgery). * Traumatic brain injury in the last three months or more than three month with neurological sequelae. * History of active neuromuscular disease that affects the muscles of head and neck or with sequels present at the time of the sensory testing (to avoid confusion with involvement of laryngopharyngeal reflexes due to neuromuscular disease). * History of cerebrovascular disease (to avoid confusion with dysphagia or sensory compromise secondary to cerebrovascular disease). * Diabetes (to avoid confusion with diabetic neuropathy that compromises the laryngopharyngeal region). * Chronic use of systemic corticosteroids at a dose greater or equal to 20 mg per day of prednisone or equivalent (to avoid confusion with steroid myopathy that compromises the laryngopharyngeal region). * Upper respiratory tract infection within 15 days prior to the testing (to avoid confusion with neuropathy associated with respiratory viral disease that compromises the laryngopharyngeal region). * Patient's inability to cooperate during the examination (to avoid measurement error caused by the lack of cooperation of the patient).
Where it's running
-
Fundacion Neumologica Colombiana
Bogotá, Bogota D.C., Colombia Recruiting -
Universidad de la Sabana
Chía, Cundinamarca, Colombia Not yet recruiting
Study contacts
- Study coordinator: Luis F Giraldo-Cadavid, MD, PhD
- Email: luisf.giraldo@unisabana.edu.co
- Phone: +573106083557
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
AI-powered sleep staging and sleep apnea screening using multimodal wearable data
This study tests AI models that use wearable and sensor data to help identify sleep stages and screen for obstructive sleep apnea in adults undergoing standard sleep testing.
-
Intensive Visual Simulation before exoskeleton gait training in people with hemisensory brain injury
This study tests whether a brief IVS session before exoskeleton-assisted walking helps people with sensory- impaired stroke-related hemiparesis to walk independently.
-
Jaw advancement with counterclockwise rotation for obstructive sleep apnea
This trial tests whether jaw advancement surgery with counterclockwise rotation helps people with moderate to severe obstructive sleep apnea who can't tolerate CPAP breathe better and sleep more soundly.
-
Eloralintide for people with obstructive sleep apnea who are overweight or obese
This study will test whether the drug eloralintide helps adults with moderate-to-severe obstructive sleep apnea who are overweight or obese, whether they use PAP therapy or not.
-
Long-term use of a nasopharyngeal airway for obstructive sleep apnea
This follow-up lets people who finished the parent trial keep using a nasopharyngeal airway to see how it works over the long term for obstructive sleep apnea.
-
How insomnia affects PAP use in children and teens with obstructive sleep apnea.
This study will see if insomnia makes children and teens with obstructive sleep apnea less likely to stick with positive airway pressure (PAP) therapy.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.